Overview

• Beth Ferguson, 30, had her breast lump initially dismissed as benign before Gartnavel Hospital diagnosed an aggressive triple-negative tumor in August 2023.
• She completed 16 rounds of chemotherapy, followed by immunotherapy and breast reconstruction surgery, and was declared in remission in May 2024.
• Ferguson now works with Breast Cancer Now and Secondary1st to advocate for targeted research and raise awareness of this challenging subtype.
• Professor Seth Coffelt at the University of Glasgow has secured a £399,670 grant to investigate immune cells that can seek and destroy triple-negative breast cancer cells.
• Triple-negative breast cancer makes up about 15% of cases, disproportionately affects younger women, and has fewer treatment options with higher risks of recurrence.